Clin2
NCT06803758Likely a fitRecruiting

Testing teicoplanin allergy with your own blood

Drug Allergy

Part of Immune system & allergy clinical trials.

This study tests a new way to check if you are allergic to the antibiotic teicoplanin using your own blood serum. It aims to help doctors know for sure if you had a severe allergic reaction during a past surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You must have had a severe allergic reaction (anaphylaxis) during anesthesia where teicoplanin was given.
  • You must be able to temporarily stop medicines that can interfere with skin tests (like antihistamines or certain antipsychotics).
  • You cannot be pregnant.
  • You cannot have a blood-borne virus (like hepatitis B, C, or HIV).
  • You cannot have a high baseline mast cell tryptase level that needs more investigation.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06406114Recruiting· Phase 2
Better Allergy Testing for Cephalosporin Antibiotics

This study tests better ways to diagnose allergies to common cephalosporin antibiotics, like Keflex and Rocephin. By participating, you may learn if you are truly allergic to these medicines and if they are safe for you to take in the future.

Scottsdale, Arizona
NCT07011212Not yet recruiting
Improving diagnosis of beta-lactam antibiotic allergy

This study aims to improve how doctors diagnose beta-lactam allergies (a common type of antibiotic allergy). It will validate a risk assessment tool and investigate the underlying causes. If you have a suspected beta-lactam allergy, this study could help you learn your true allergy status.

NCT05580055Enrolling by invitation
Blood testing for healthy adults

This study tests a new blood testing device on healthy adults to see if it works well and is easy to use. It may help improve how blood tests are done in the future.

London, London
NCT06674330Not yet recruiting
Finding the right teicoplanin dose for blood cancer or critically ill patients

This study is testing a smarter way to give the antibiotic teicoplanin to people with blood cancers or severe illnesses. The goal is to make sure each person gets the right dose to fight the infection while reducing side effects.

NCT06409884Recruiting
Amoxicillin allergy testing trial

This trial is testing a new way to diagnose allergies to amoxicillin, a common antibiotic. It may help people who think they might be allergic to amoxicillin find out for sure.

Edegem, Antwerp
NCT04751760Recruiting
Test a new blood test for IgE allergy markers

This study checks whether a new blood test can measure allergy-related immune signals (IgE) in people with known or suspected allergies. If it works well, it could help doctors diagnose and track IgE allergies more easily.

Toulouse

Hear when a new Drug Allergy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.